Search Results - Biziotis, Olga‐Demetra

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

    Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α by Biziotis, Olga‐Demetra, Tsakiridis, Evangelia Evelyn, Ali, Amr, Ahmadi, Elham, Wu, Jianhan, Wang, Simon, Mekhaeil, Bassem, Singh, Kanwaldeep, Menjolian, Gabe, Farrell, Thomas, Abdulkarim, Bassam, Sur, Ranjan K., Mesci, Aruz, Ellis, Peter, Berg, Tobias, Bramson, Jonathan L, Muti, Paola, Steinberg, Gregory R, Tsakiridis, Theodoros

    Published in Molecular oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses

    Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses by Tsakiridis, Evangelia E., Broadfield, Lindsay, Marcinko, Katarina, Biziotis, Olga-Demetra, Ali, Amr, Mekhaeil, Bassem, Ahmadi, Elham, Singh, Kanwaldeep, Mesci, Aruz, Zacharidis, Panayiotis G., Anagnostopoulos, Alexander E., Berg, Tobias, Muti, Paola, Steinberg, Gregory R., Tsakiridis, Theodoros

    Published in Translational oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

    The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy by Ali, Amr, Mekhaeil, Bassem, Biziotis, Olga-Demetra, Tsakiridis, Evangelia E., Ahmadi, Elham, Wu, Jianhan, Wang, Simon, Singh, Kanwaldeep, Menjolian, Gabe, Farrell, Thomas, Mesci, Aruz, Liu, Stanley, Berg, Tobias, Bramson, Jonathan L., Steinberg, Gregory R., Tsakiridis, Theodoros

    Published in Communications biology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy

    Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy by Di Pastena, Fiorella, Pond, Gregory, Tsakiridis, Evangelia E, Gouveia, Andre, Ahmadi, Elham, Biziotis, Olga-Demetra, Ali, Amr, Swaminath, Anand, Okawara, Gordon, Ellis, Peter M, Abdulkarim, Bassam, Ahmed, Naseer, Robinson, Andrew, Roa, Wilson, Valdes, Mario, Kavsak, Peter, Wierzbicki, Marcin, Wright, James, Steinberg, Gregory, Tsakiridis, Theodoros

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

    18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer by Mesci, Aruz, Ahmadi, Elham, Ali, Amr, Gouran-Savadkoohi, Mohammad, Evelyn Tsakiridis, Evangelia, Biziotis, Olga-Demetra, Chow, Tom, Kapoor, Anil, Sur, Monalisa, Steinberg, Gregory R., Liu, Stanley, Zukotynski, Katherine, Tsakiridis, Theodoros

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy

    40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy by Biziotis, Olga-Demetra, Tsakiridis, Evangelia - Evelyn, Broadfield, Lindsay, Farrell, Thomas, Menjolian, Gabe, Mathurin, Tammy, Mekhaeil, Bassem, Zacharidis, Panagiotis, Muti, Paola, Abdulkarim, Bassam, Steinberg, Gregory, Tsakiridis, Theodoros

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy

    167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy by Mekhaeil, Bassem, Zacharidis, Panagiotis, Tsakiridis, Evelyn, Biziotis, Olga-Demetra, Broadfield, Lindsay, Menjolian, Gabe, Mathurin, Tammy, Farrell, Thomas, Muti, Paola, Liu, Stanley, Steinberg, Gregory, Tsakiridis, Theodoros

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    18 F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

    18 F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer by Mesci, Aruz, Ahmadi, Elham, Ali, Amr, Gouran-Savadkoohi, Mohammad, Evelyn Tsakiridis, Evangelia, Biziotis, Olga-Demetra, Chow, Tom, Kapoor, Anil, Sur, Monalisa, Steinberg, Gregory R, Liu, Stanley, Zukotynski, Katherine, Tsakiridis, Theodoros

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: